Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • United States

    Tag: united states

    You Searched For "United States"
    Swiss company Actelion moves US court against Natco Pharma over generic of its patented drug

    Swiss company Actelion moves US court against Natco Pharma over generic of its patented drug

    Medical Dialogues Bureau5 Jun 2019 12:27 PM IST
    Hyderabad: Swiss pharma company Actelion Pharmaceuticals Ltd has filed a petition in a US court alleging that Natco Pharma and its US partner Syneos...
    Roche, GE Healthcare launch NAVIFY Tumor Board to enable personalised treatment decisions in cancer care

    Roche, GE Healthcare launch NAVIFY Tumor Board to enable personalised treatment decisions in cancer care

    Medical Dialogues Bureau3 Jun 2019 9:45 AM IST
    The new version of NAVIFY Tumor Board is initially available in the United States and Canada with additional markets to follow in the near future.New...
    Natco Pharma settles patent litigation with Onyx Therapeutics over anti cancer drug- Kyprolis

    Natco Pharma settles patent litigation with Onyx Therapeutics over anti cancer drug- Kyprolis

    Medical Dialogues Bureau1 Jun 2019 2:39 PM IST
    New Delhi: Natco Pharma Thursday said it has settled patent litigation with Onyx Therapeutics Inc in the US over a generic version of Kyprolis, an...
    Natco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis

    Natco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis

    Medical Dialogues Bureau30 May 2019 5:12 PM IST
    Kyprolis is the trade name for the generic drug Carfilzomib. The anti-cancer drug is a targeted therapy and is classified as a Proteasome Inhibitor....
    Sun Pharma Q4 profit falls by half to Rs 636 crore due to change in distribution strategy

    Sun Pharma Q4 profit falls by half to Rs 636 crore due to change in distribution strategy

    Garima29 May 2019 9:45 AM IST
    Sun Pharma said the net profit for the fourth quarter of FY2018-19 is not comparable with the year-ago period due to the one-time impact of...
    US impose sanctions on network of online pharmacies for opioids

    US impose sanctions on network of online pharmacies for opioids

    Medical Dialogues Bureau25 May 2019 9:15 AM IST
    The move was the latest effort by the Trump Administration to tackle the U.S. epidemic of abuse and overdoses linked to prescription painkillers and...
    GSK reintroduce incentives for sales representatives

    GSK reintroduce incentives for sales representatives

    Farhat Nasim24 May 2019 9:31 AM IST
    GSK said it would make changes to its incentive program for pharmaceutical and vaccines sales representatives, to be applied initially in the United...
    Panacea Biotec gets USFDA nod for chemotherapy drug Azacitidine

    Panacea Biotec gets USFDA nod for chemotherapy drug Azacitidine

    Farhat Nasim22 May 2019 9:45 AM IST
    Azacitidine is a chemotherapy drug used to treat myelodysplastic syndromes (MDS) with annual sales of about USD 110 million in US markets as per IQVIA...
    Cadila Healthcare gets 14 USFDA observations for Moraiya plant

    Cadila Healthcare gets 14 USFDA observations for Moraiya plant

    Farhat Nasim4 May 2019 10:00 AM IST
    The US Food and Drug Administration (USFDA) inspected the plant from April 22, 2019 to May 3, 2019, Cadila Healthcare said in a regulatory filing.New...
    Sanofi wins USFDA approval to sell dengue vaccine Dengvaxia in parts of US

    Sanofi wins USFDA approval to sell dengue vaccine Dengvaxia in parts of US

    Farhat Nasim2 May 2019 10:00 AM IST
    Dengvaxia is a live, attenuated vaccine that is administered as three separate injections, with the initial dose followed by two additional shots...
    GSK expects shingles drug sales to exceed $1.3 billion

    GSK expects shingles drug sales to exceed $1.3 billion

    Garima2 May 2019 9:00 AM IST
    FTSE-100 member GSK, whose shares were up 0.3 per cent to 1,580 pence at 1156 GMT, also said it had decided to stop the clinical development of its...
    USFDA declines to approve Nabriva

    USFDA declines to approve Nabriva's antibiotic Contepo for urinary tract infections

    Medical Dialogues Bureau1 May 2019 12:02 PM IST
    The U.S. Food and Drug Administration on Tuesday declined to approve Nabriva Therapeutics Plc's antibiotic Contepo for complicated urinary tract...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok